NovoCure: Q3 Earnings Insights

Loading...
Loading...

NovoCure NVCR reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

NovoCure beat estimated earnings by 3.85%, reporting an EPS of $-0.25 versus an estimate of $-0.26.

Revenue was down $2.61 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 3.2% drop in the share price the next day.

Here's a look at NovoCure's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.15 -0.18 -0.10 -0.07
EPS Actual -0.23 -0.04 -0.25 -0.13
Revenue Estimate 134.99M 134.08M 135.42M 141.76M
Revenue Actual 140.87M 137.55M 133.21M 133.61M

To track all earnings releases for NovoCure visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...